GICS Roundup: PD-1 Inhibitor Yields 100% Response Rate in dMMR Rectal Cancer
Plus: Promising activity in <em>BRAF</em>-mutant CRC, L-asparaginase drug falls short in pancreatic cancer
Source: medpagetoday.com
Stay updated with breaking news from Boosts Activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Plus: Promising activity in <em>BRAF</em>-mutant CRC, L-asparaginase drug falls short in pancreatic cancer